Metformin in the context of "Metabolic syndrome"

Play Trivia Questions online!

or

Skip to study material about Metformin in the context of "Metabolic syndrome"

Ad spacer

⭐ Core Definition: Metformin

Metformin, sold under the brand name Glucophage, among others, is the main first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome, and is sometimes used as an off-label adjunct to lessen the risk of metabolic syndrome in people who take antipsychotic medication. It has been shown to inhibit inflammation, and is not associated with weight gain. Metformin is taken by mouth.

Metformin is generally well tolerated. Common adverse effects include diarrhea, nausea, and abdominal pain. It has a small risk of causing low blood sugar. High blood lactic acid level (acidosis) is a concern if the medication is used in overly large doses or prescribed in people with severe kidney problems.

↓ Menu

>>>PUT SHARE BUTTONS HERE<<<
In this Dossier

Metformin in the context of Diabetes

Diabetes mellitus, commonly known as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough of the hormone insulin or the cells of the body becoming unresponsive to insulin's effects. Classic symptoms include the three Ps: polydipsia (excessive thirst), polyuria (excessive urination), polyphagia (excessive hunger), weight loss, and blurred vision. If left untreated, the disease can lead to various health complications, including disorders of the cardiovascular system, eye, kidney, and nerves. Diabetes accounts for approximately 4.2 million deaths every year, with an estimated 1.5 million caused by either untreated or poorly treated diabetes.

The major types of diabetes are type 1 and type 2. The most common treatment for type 1 is insulin replacement therapy (insulin injections), while anti-diabetic medications (such as metformin and semaglutide or tirzepatide) and lifestyle modifications can be used to manage type 2. Gestational diabetes, a form that sometimes arises during pregnancy, normally resolves shortly after delivery. Type 1 diabetes is an autoimmune condition where the body's immune system attacks the beta cells (β-cell) in the pancreas, preventing the production of insulin. This condition is typically present from birth or develops early in life. Type 2 diabetes occurs when the body becomes resistant to insulin, meaning the cells do not respond effectively to it, and thus, glucose remains in the bloodstream instead of being absorbed by the cells. Additionally, diabetes can also result from other specific causes, such as genetic conditions (monogenic diabetes syndromes like neonatal diabetes and maturity-onset diabetes of the young), diseases affecting the pancreas (such as pancreatitis), or the use of certain medications and chemicals (such as glucocorticoids, other specific drugs and after organ transplantation).

↑ Return to Menu

Metformin in the context of Marrow adipose tissue

Bone marrow adipose tissue (BMAT), also referred to as marrow adipose tissue (MAT), is a type of adipose tissue (fat deposit) found within the bone marrow. BMAT increases in conditions associated with low bone density, such as osteoporosis, anorexia nervosa and caloric restriction, and skeletal weightlessness such as that occurring during spaceflight. It has also been linked to certain anti-diabetic therapies.

Conversely, BMAT decreases in conditions such as anaemia, leukaemia, and hypertensive heart failure; in response to hormones including oestrogen, leptin, and growth hormone; with exercise-induced weight loss or bariatric surgery; following chronic cold exposure; and after treatment with pharmacological agents such as bisphosphonates, teriparatide, and metformin.

↑ Return to Menu